Transform Wealth’s Allergan plc AGN Stock Holding History

Transform Wealth’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,278	Closed	-$989K	–	218
2016 Q2	$989K	Buy	+4,278	New	+$986K	0.42%	82

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Transform Wealth's AGN Position: Q3 2016 in Review

Transform Wealth sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 4,278 shares — an estimated $989K sold.

Transform Wealth first reported a position in AGN in Q2 2016 and held it in 1 quarter. The position peaked at $989K in Q2 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Transform Wealth reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
Transform Wealth sold 4,278 Allergan plc shares in Q3 2016, an estimated $989K.
Transform Wealth first reported a position in Allergan plc in Q2 2016 and held it in 1 quarter.
Transform Wealth's Allergan plc position peaked at $989K in Q2 2016.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Transform Wealth's 13F filing for Q3 2016, filed 7 Nov 2016.